When: Gross margin ≥36%, EBITDA margin ≥22%, revenue growth ≥7%, no incremental restructuring charges

Then: Add back trimmed exposure

When: Second Tier-1 upgrade from Goldman, JPM, or BofA corroborating Morgan Stanley view

Then: Add back trimmed exposure

TRIM

• Price sitting 20.5 percent below both the 50 and 200 SMA, with MACD deeply negative at minus 12.49
• August 19 Morgan Stanley upgrade catalyst hit 170.37 with 7.28 million shares of volume but closed at 165.89 the next session
• Failed to close above the 10 EMA for nine consecutive sessions
• Gross margin compressed 250 basis points from 37.5 percent in Q1 to 35.0 percent in Q2
• Revenue growth decelerated from 12.7 percent in 2025 to 5.4 percent in Q2 2026
• EBITDA collapsed 37 percent year-over-year
• 577 million inventory build flagged as potential demand softening indicator
• Forward EPS of 9.11 requires four simultaneous conditions: SG&A normalization (700 million cost reduction), gross margin recovery above 37 percent, revenue reacceleration to 8-10 percent, and tax rate settling to 17 percent
• ATR of 12.18 dollars represents 7.3 percent of price in daily volatility
• 15.9 billion in debt against negative book equity
• Next major catalyst (Q3 2026 earnings) approximately 60-90 days away
• 155 stop represents 155 dollar support level; 139 Bollinger lower band represents 16 percent move from current levels

→ vs aggressive: The 'coiled spring' technical argument is narrative bias rather than tape reading; the August 19 spike with 7.28 million shares was the exact catalyst described yet failed to hold, proving the spring narrative wrong

→ vs aggressive: Dismissing Q2 fundamentals as noise ignores 250 basis points of gross margin compression, 37 percent EBITDA collapse, and revenue deceleration from 12.7 percent to 5.4 percent; the 577 million inventory build could signal demand softening rather than strategic positioning

→ vs aggressive: The 'hawkish Fed already priced in' argument ignores tail risk; 14 percent probability of cuts creates asymmetric downside if rates remain elevated or push higher, compressing multiples further on a high-multiple industrial

→ vs aggressive: 1.5x to 2x position sizing on a stock with 7.3 percent daily volatility and 20 percent overhead resistance is concentrated tail risk, not conviction; a 2x sized position hitting a 155 stop means 13 percent capital loss on a single name

→ vs aggressive: The 8 percent recession probability is the implied probability today and can move violently; the trade doesn't need a recession to break, just a hawkish hold persisting longer than the bull case assumes

MODIFIED SELL: Trim 20-25% of existing long exposure at $165.89, maintain 75-80% core position with stop at $155 (6.5% downside), set re-entry trigger at decisive close above $172 on volume above 4M shares with RSI pushing above 50 and MACD histogram crossing positive, reassess at Q3 2026 earnings

• Morgan Stanley upgrade has institutional credibility with 9% intraday move on real volume and 7.28M shares of volume on August 19
• DCF analysis shows stock below intrinsic fair value; 18.2x forward EPS is mid-range for aerospace primes
• Defense procurement tailwind with Tomahawk contract and broader aerospace cycle is a real multi-year catalyst
• Debt exchange closed with high bondholder participation, signaling management confidence in cash flow
• Revenue deceleration from 12.7% in 2025 to 5.4% in Q2 2026 is a confirmed operational signal being glossed over
• $577M inventory build is genuinely ambiguous and cannot be dismissed as transition noise
• EBITDA declined from $1,110M in Q2 2025 to $700M in Q2 2026, a 37% drop that is not transition noise
• ATR is $12.18 (7.3% of price), making 1.5x-2x position sizing equivalent to a 11-15% bet on a single name
• Stock is down 15.85% in 30 days and 14.82% YTD; much of the deterioration is already priced in
• Price sits 20.5% below both the 50 and 200 SMA with 9 consecutive failed closes above 10 EMA
• MACD at minus 12.49 is deeply negative; institutional bid at $165 provides real floor support
• $9.11 forward EPS requires 4 simultaneous conditions: SG&A normalization, gross margin recovery, growth re-acceleration, and tax rate settling
• Q3 2026 earnings in 60-90 days is the catalyst that will resolve the bull-bear debate
• Proposed trim of 20-25% at $165.89 reduces exposure while preserving ability to participate in upside resolution

→ vs aggressive: Coiled spring framing is narrative bias; 7.28M shares volume on Morgan Stanley upgrade (Aug 19) didn't hold the line, contradicting the volume threshold thesis

→ vs aggressive: Dismissal of Q2 fundamentals is too convenient; 250bps gross margin compression, revenue deceleration from 12.7% to 5.4%, and ambiguous $577M inventory build cannot all be 'transition noise'

→ vs aggressive: 1.5x-2x sizing with ATR at $12.18 (7.3% of price) creates 11-15% single-name exposure, not the 6.5% presented; this is reckless compounding of error with leverage

→ vs aggressive: Hawkish Fed being 'priced in' treats 86% probability as static when it is a moving target; the pivot thesis is a hope, not a tradeable catalyst

→ vs conservative: Bear case signals are already in the price; stock down 15.85% in 30 days and 14.82% YTD means the deterioration being priced in has largely already happened

→ vs conservative: Institutional bid at $165 is real and providing support; absence of follow-through selling after the upgrade proves market hasn't capitulated

→ vs conservative: 33-50% trim crystallizes losses at a potentially wrong level; if stock reverses to $184 after trimming 50%, the opportunity cost becomes permanent and significant

→ vs conservative: The asymmetry being protected against is not necessarily better than the asymmetry created by being too defensive too early